RCI
ONCS

Ridgeback Capital Investments’s OncoSec Medical Incorporated ONCS Stock Holding History

Ridgeback Capital Investments’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,876
Closed -$3.06M – 4
2015
Q4 		$3.06M Buy
+5,876
New +$4.42M 13.18% 4

Other funds holding ONCS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Ridgeback Capital Investments's ONCS Position: Q1 2016 in Review

Ridgeback Capital Investments sold out of OncoSec Medical Incorporated (ONCS) in Q1 2016, closing a stake of 5,876 shares — an estimated $3.06M sold.

Ridgeback Capital Investments first reported a position in ONCS in Q4 2015 and held it in 1 quarter. The position peaked at $3.06M in Q4 2015. 20 funds tracked by Wall St. Rank hold ONCS as of Q1 2016.

  • Ridgeback Capital Investments reported no remaining OncoSec Medical Incorporated position as of Q1 2016 after selling out during the quarter.
  • Ridgeback Capital Investments sold 5,876 OncoSec Medical Incorporated shares in Q1 2016, an estimated $3.06M.
  • Ridgeback Capital Investments first reported a position in OncoSec Medical Incorporated in Q4 2015 and held it in 1 quarter.
  • Ridgeback Capital Investments's OncoSec Medical Incorporated position peaked at $3.06M in Q4 2015.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2016.

Based on Ridgeback Capital Investments's 13F filing for Q1 2016.